Form D · Pharmaceuticals
Research Discovery Innovation Inc.
Chicago, IL · CIK 0002147879
Offering snapshot reported Jul 29, 2026 · SEC filing
- Reported sold
- $39 Offering amount: $39
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 20, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 29, 2026 | Initial | $39 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-592454
Restricted common stock issued as compensation for advisory services previously rendered: 38,265 shares at $0.001 per share, aggregate value $38.27 (shown rounded to $39). No cash proceeds.
Source: Form D, filed Jul 29, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Stig Lofberg | Executive |
| Christina Lofberg Kaij | Executive |
| Bo Von Barnekow Lofberg | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
875 N Michigan Avenue Suite 3950
Chicago, IL, 60611
Phone: 312-787-8780
Chicago, IL, 60611
Phone: 312-787-8780